Contract on 15 MeV Electron Linear Accelerator (LINAC) confirms RI Research Instruments' global leadership in turn-key accelerators, and is the first major order for RI Research Instruments, formerly part of ACCEL Instruments.
BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--May. 4, 2009-- RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Advanced Supercon, Inc., announced today the finalization of an approximately $4 million contract with Radboud University in Nijmegen, The Netherlands, for a turn-key infrared free electron laser (IR FEL) driver.
The contract covers the development, production, installation and commissioning of an 8-15 MeV pulsed LINAC with parameters suitable to drive the IR FEL, which will be developed in parallel by the team at Radboud University.
The contract is the first major order received by RI Research Instruments GmbH since the formation of this company in connection with Bruker’s April 1, 2009 acquisition of the research instruments business of ACCEL Instruments from Varian Medical Systems.
Dr. Michael Peiniger, Managing Director of RI Research Instruments, explained: “This new contract ideally complements our work on the 150 MeV LINAC for the Taiwan Photon Source and the production of S-Band accelerating cavities for the Paul Scherrer Institut in Switzerland. Besides high micro pulse charge at low energy spread, the requirements of building a compact and efficient electron source make this project a new challenge for the teams at RI Research Instruments and Radboud University. This new LINAC project demonstrates continuity in serving our customers, and we are grateful to Radboud University for the confidence expressed in RI with this order.”
About RI Research Instruments and Bruker Advanced Supercon:
RI Research Instruments GmbH is a world leader in the development and manufacturing of rf cavities and systems, linear accelerators, and special products for physics and energy research, scientific, medical, and industrial applications. RI products include electron and ion sources, LINACs, normal and super-conducting accelerator cavities, other accelerator components, neutron source subunits, particle beam lines, as well as vacuum and cryogenic systems. RI Research Instruments was formed as a result of Bruker Advanced Supercon’s April 1, 2009 acquisition of the research instruments business of ACCEL Instruments GmbH from Varian Medical Systems. Bruker has acquired a majority stake in RI Research Instruments and has retained Dr. Michael Peiniger as Managing Director and the former ACCEL management team as minority (45%) shareholders in the newly formed company. Bruker Advanced Supercon, Inc. of Billerica, MA is a wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR) and has operations in the U.S., the UK and Germany.
Source: Bruker Advanced Supercon, Inc.
RI Research Instruments
Dr. Michael Peiniger, +49 2204 843676
Managing Director
michael.peiniger@research-instruments.de